Lipo-C

Precios por volumen

Precio por envase (10 viales). El descuento se aplica únicamente a este compuesto; no se admiten combinaciones.

Lipo-C — Compounded Lipotropic Injection | MIC + L-Carnitine + B-Vitamin Complex

Lipo-C is a multi-component compounded lipotropic injection combining amino acid methyl donors, a mitochondrial fatty acid transporter, and B-vitamin cofactors into a single parenteral preparation. Unlike single-compound peptide injections, Lipo-C is a synergistic formulation — each ingredient targets a distinct step in the hepatic fat mobilization and mitochondrial fat oxidation cascade, with the combined preparation demonstrating greater lipotropic activity than any individual component administered alone. The injectable route bypasses gastrointestinal absorption limitations that significantly restrict the bioavailability of oral versions of these compounds, particularly L-carnitine, where parenteral delivery produces effective blood levels at a fraction of the oral dose required.

Why Multi-Pathway Coverage Defines Lipo-C’s Research Utility

Hepatic fat accumulation and impaired mitochondrial fatty acid oxidation rarely stem from a single deficiency — they reflect dysfunction across interconnected metabolic steps. Lipo-C targets three distinct bottlenecks simultaneously:

First, the hepatic export step: the liver cannot package and export triglycerides as VLDL particles without sufficient phosphatidylcholine. Both methionine (via S-adenosylmethionine) and choline serve as direct precursors to phosphatidylcholine synthesis. Choline deficiency alone is sufficient to cause hepatic steatosis in animal models.

Second, the transport and signaling step: inositol modulates insulin receptor sensitivity and reduces insulin resistance-driven fatty acid synthesis, while choline supports lipoprotein assembly for systemic fatty acid distribution.

Third, the mitochondrial oxidation step: L-carnitine functions as the essential shuttle that transfers long-chain fatty acyl-CoA esters across the inner mitochondrial membrane — without it, fatty acids cannot enter the beta-oxidation pathway regardless of how effectively they were mobilized from hepatic stores.

Aplicaciones de investigación

Lipo-C is used in studies examining:

• Hepatic lipid metabolism and non-alcoholic fatty liver disease (NAFLD) models — particularly the role of choline and methionine deficiency in steatosis development and reversal
• Mitochondrial fatty acid oxidation capacity and the role of carnitine availability as a rate-limiting variable in beta-oxidation
• Insulin resistance and inositol’s modulation of PI3K-dependent insulin signaling in liver and adipose tissue models
• Body composition outcomes under caloric restriction — lean mass preservation via methionine-supported protein synthesis and nitrogen balance
• Methylation pathway research: SAM-dependent epigenetic regulation, histone methylation, and gene expression modulation
• Synergistic lipotropic activity in combination formulations versus isolated component studies
• Parenteral versus oral bioavailability comparisons for carnitine, choline, and B-vitamin cofactors
• Metabolic support protocols adjunct to GLP-1 receptor agonist research

Especificaciones

Administration Notes

Lipo-C arrives as a ready-to-use sterile solution — no reconstitution required. Inspect the vial before each use; the solution should be clear and free of particulates. Standard research protocols administer 1–2mL per injection via intramuscular (IM) or subcutaneous (SC) route, 1–3 times per week depending on study design and endpoints. The 10mL multidose vial provides approximately 5–10 administrations depending on volume per injection.

Store at 2–8°C throughout use. Keep vial sealed between administrations and discard per your lab’s multi-dose vial policy (typically within 28–30 days of first use). Do not freeze.

Notas sobre el protocolo

Research dosing framework:

• Standard dose: 1mL per administration (full-concentration per-mL delivery of all components)
• Volume range: 1–2mL per injection depending on endpoint
• Frequency: 1–3×/week; most protocols use 2×/week for metabolic and body composition endpoints
• Duration: 8–12 week studies for body composition endpoints; shorter windows (4–6 weeks) used in acute hepatic function or insulin sensitivity models
• Timing: Fasted-state or pre-exercise administration is commonly used in fat mobilization research to align injection with peak lipolytic signaling

Efectos observados con frecuencia en modelos de investigación:

• Metabolic: Improved hepatic fat export markers; increased fatty acid oxidation indices; modest improvements in insulin sensitivity at standard doses
• Energy/CNS: Elevated energy expenditure markers in animal models; acetylcholine-mediated CNS activity increase via choline pathway
• Injection site: Mild burning or warmth at injection site due to formulation pH; slow IM administration (over 30 seconds) minimizes discomfort; rotate sites systematically
• Other: Transient fishy body odor possible with repeated dosing — benign, attributable to choline/carnitine conversion to trimethylamine by gut bacteria; resolves within 24–48 hours

Pilas de investigación

Lipo-C is commonly paired in research settings with:

• Glutathione — Glutathione is the primary endogenous antioxidant and plays a central role in hepatic detoxification; co-administration with Lipo-C’s methionine and choline components is studied in models of hepatic lipid metabolism and oxidative stress, where both compounds converge on mitochondrial function and cellular redox balance.
• NAD+ — NAD+ is an essential coenzyme in mitochondrial energy metabolism and sirtuin-mediated metabolic regulation; pairing with Lipo-C’s B-vitamin and lipotropic components is studied to examine coordinated effects on hepatic fat oxidation and cellular energy substrate availability.
• Vitamin B12 — B12 participates in methionine synthesis and one-carbon metabolism, the same biochemical network that Lipo-C’s methionine and inositol components support; researchers pair them to study cofactor completeness within the methylation and lipid transport pathway.

Garantía de pureza

Cada lote tiene una pureza ≥99 % por componente. Si sometes tu compuesto a un análisis independiente y los resultados no coinciden, envíanos el certificado de análisis (COA) y te concederemos un crédito en la tienda sin hacerte preguntas.